Clinical Trials · NCT01279187

The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone

TerminatedPhase 2Teriparatide (Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
University of Michigan
Enrollment
27
Start date
Feb 2011
Locations
1 site, United States
Primary endpoint
Bone Formation Rate
View Teriparatide compound reference